Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Rybnik

13 clinical trials in Rybnik, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Rybnik at a glance
13
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

13 trials in Rybnik

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Alcoholism

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Oxybate
  • Sponsor:Laboratorio Farmaceutico C.T. S.r.l.

Dyslipidaemia

Recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rbd5044 Sodium
  • Sponsor:Ribocure Pharmaceuticals AB

Arteriosclerosis

Not yet recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Faricimab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG

Multiple sclerosis+1

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Methylprednisolone
  • Sponsor:F. Hoffmann-La Roche AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Malignant melanoma

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Rybnik

What the registry says about research in the country

01 Neurology Research

Groundbreaking studies focusing on Primary Progressive Multiple Sclerosis (PPMS), evaluating advanced treatment options and their effectiveness in managing disease progression.

  • Disease Progression Assessment
  • Treatment Optimization
  • Disability Management

Multiple trials are exploring higher dosing protocols and comparing treatment efficacy against established standards.

02 Oncology Studies

Innovative research examining treatments for metastatic cancer and high-risk melanoma, with emphasis on improving patient outcomes through targeted therapies.

  • Cancer Recurrence Prevention
  • HER2-Positive Cancer Treatment
  • Immunotherapy Applications

Studies include both adjuvant therapy protocols and extended treatment investigations for various cancer types.

03 Neurological Emergency Care

Critical research addressing acute ischemic stroke and high-risk transient ischemic attacks, focusing on preventive treatments and risk reduction strategies.

  • Stroke Prevention
  • Emergency Intervention
  • Risk Management

Trials are evaluating new therapeutic approaches to reduce recurrent stroke risk in high-risk patients.

04 Addiction Medicine

Innovative studies examining treatments for alcohol dependence, with focus on reducing consumption patterns and maintaining long-term abstinence.

  • Consumption Reduction
  • Abstinence Maintenance
  • Treatment Safety Assessment

Research emphasizes therapeutic interventions for patients with high and very high drinking risk levels.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.